CHRISTINE WEISS: Open Payments
NPI 1376986687 · MALVERNE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 13 payments from 9 companies in 2025. Trend: 2023 $367 · 2024 $254 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Exact Sciences Corporation | 1 | $34 |
| PFIZER INC. | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Ozempic, LEQVIO, GARDASIL 9, Cologuard Collection Kit, NEXLETOL, CAPLYTA, MOUNJARO, SHINGRIX.
Industry payments across NY — which companies pay providers there.
